SK8132001A3 - Sulphonyloxazolamines as therapeutic active ingredients - Google Patents

Sulphonyloxazolamines as therapeutic active ingredients Download PDF

Info

Publication number
SK8132001A3
SK8132001A3 SK813-2001A SK8132001A SK8132001A3 SK 8132001 A3 SK8132001 A3 SK 8132001A3 SK 8132001 A SK8132001 A SK 8132001A SK 8132001 A3 SK8132001 A3 SK 8132001A3
Authority
SK
Slovakia
Prior art keywords
formula
oxazol
compounds
amine
benzenesulfonyl
Prior art date
Application number
SK813-2001A
Other languages
English (en)
Slovak (sk)
Inventor
Hartmut Greiner
Gerd Bartoszyk
Henning Bottcher
Gerhard Barnickel
Bertram Cezanne
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of SK8132001A3 publication Critical patent/SK8132001A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/48Nitrogen atoms not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK813-2001A 1998-12-18 1999-12-01 Sulphonyloxazolamines as therapeutic active ingredients SK8132001A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19858593A DE19858593A1 (de) 1998-12-18 1998-12-18 Sulfonyloxazolamine als therapeutische Wirkstoffe
PCT/EP1999/009335 WO2000037452A1 (de) 1998-12-18 1999-12-01 Sulfonyloxazolamine als therapeutische wirkstoffe

Publications (1)

Publication Number Publication Date
SK8132001A3 true SK8132001A3 (en) 2002-02-05

Family

ID=7891645

Family Applications (1)

Application Number Title Priority Date Filing Date
SK813-2001A SK8132001A3 (en) 1998-12-18 1999-12-01 Sulphonyloxazolamines as therapeutic active ingredients

Country Status (19)

Country Link
US (1) US6441013B1 (id)
EP (1) EP1140875A1 (id)
JP (1) JP2002533332A (id)
CN (1) CN1146549C (id)
AR (1) AR021896A1 (id)
AU (1) AU763070B2 (id)
BR (1) BR9916310A (id)
CA (1) CA2356134A1 (id)
CZ (1) CZ20012144A3 (id)
DE (1) DE19858593A1 (id)
HK (1) HK1043125A1 (id)
HU (1) HUP0104834A3 (id)
ID (1) ID29966A (id)
NO (1) NO20012965D0 (id)
PL (1) PL349393A1 (id)
RU (1) RU2232757C2 (id)
SK (1) SK8132001A3 (id)
WO (1) WO2000037452A1 (id)
ZA (1) ZA200105881B (id)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19956791A1 (de) * 1999-11-25 2001-05-31 Merck Patent Gmbh Neue Sulfonyloxazolamine
DE10129940A1 (de) * 2001-06-13 2002-12-19 Merck Patent Gmbh Sulfonyloxazolamine als therapeutische Wirkstoffe
US6875771B2 (en) * 2002-07-26 2005-04-05 Bristol-Myers Squibb Company Pyridopyrimidine derivatives as 5-HT6 antagonists
FR2854632B1 (fr) * 2003-05-07 2005-06-17 Centre Nat Rech Scient Synthese de composes heterocycliques substitues
DK1831159T3 (da) * 2004-12-21 2010-03-22 Hoffmann La Roche Tetralin og indanderivater samt anvendelser deraf
SG172738A1 (en) * 2005-07-29 2011-07-28 4Sc Ag Novel heterocyclic nf-kb inhibitors
WO2008061248A2 (en) * 2006-11-16 2008-05-22 The Regents Of The University Of California Phenylsulfoxyoxazole compound inhibitors of urea transporters
KR101174191B1 (ko) * 2007-02-02 2012-08-14 에프. 호프만-라 로슈 아게 중추 신경계 장애의 치료용 taar1 리간드로서 2-아미노옥사졸린
WO2008098857A1 (en) * 2007-02-15 2008-08-21 F. Hoffmann-La Roche Ag 2-aminooxazolines as taar1 ligands
RU2443697C1 (ru) 2010-12-21 2012-02-27 Александр Васильевич Иващенко Замещенные метил-амины, антагонисты серотониновых 5-ht6 рецепторов, способы получения и применения
CN109789129B (zh) * 2016-07-12 2022-04-29 延世大学校产学协力团 自噬改良材料及其用途
KR102533605B1 (ko) * 2018-01-10 2023-05-17 주식회사 라이조테크 신규한 페닐설포닐 옥사졸 유도체 및 이의 용도

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0002351A3 (en) 1996-02-20 2001-10-29 Bristol Myers Squibb Co Methods for the preparation of biphenyl isoxazole sulfonamides, intermediates and process for preparing them

Also Published As

Publication number Publication date
ID29966A (id) 2001-10-25
BR9916310A (pt) 2001-11-06
EP1140875A1 (de) 2001-10-10
ZA200105881B (en) 2002-10-17
HUP0104834A3 (en) 2005-06-28
JP2002533332A (ja) 2002-10-08
HK1043125A1 (zh) 2002-09-06
US6441013B1 (en) 2002-08-27
DE19858593A1 (de) 2000-06-21
AR021896A1 (es) 2002-08-07
WO2000037452A1 (de) 2000-06-29
HUP0104834A2 (hu) 2002-07-29
NO20012965L (no) 2001-06-15
RU2232757C2 (ru) 2004-07-20
NO20012965D0 (no) 2001-06-15
CA2356134A1 (en) 2000-06-29
PL349393A1 (en) 2002-07-15
CN1146549C (zh) 2004-04-21
AU1861200A (en) 2000-07-12
CN1331684A (zh) 2002-01-16
AU763070B2 (en) 2003-07-10
CZ20012144A3 (cs) 2002-01-16

Similar Documents

Publication Publication Date Title
Turner et al. Antihypertensive thiadiazoles. 2. Vasodilator activity of some 2-aryl-5-guanidino-1, 3, 4-thiadiazoles
SK8132001A3 (en) Sulphonyloxazolamines as therapeutic active ingredients
HU213113B (en) Process for producing 2-aminobenzoxazole and 2-amino-benzothiazole derivatives and pharmaceutical compositions containing them
SK122099A3 (en) Substituted 4-arylmethylene-2-imino-2,3-dihydrothiazoles and derivatives and their pharmaceutical use
SK281457B6 (sk) 3-[4-(4-(4-kyánfenyl)-1-piperazinyl)butyl]-5-kyánindol, spôsob jeho prípravy, jeho použitie a farmaceutický prostriedok, ktorý ho obsahuje
KR100417506B1 (ko) 항우울 치료를 위한 5ht1 길항제
CZ20011551A3 (cs) Derivát benzoylpyridazinu, způsob jeho přípravy a farmaceutický prostředek, který ho obsahuje
FI89915B (fi) Foerfarande foer framstaellning av psykotropiska acykliska amidderivat
SK112799A3 (en) Oxazolidinones, preparation method and use thereof, pharmaceutical compositions
US6737426B1 (en) Sulfonyloxazoleamines
WO2002100842A1 (en) Sulfonyloxazolamines and their use as 5-ht6 ligands
KR20010086457A (ko) 치료 활성 화합물로서의 술포닐옥사졸아민류
CZ20033194A3 (cs) Deriváty 6H-oxazolo[4,5-e]indolu jako ligandy nikotinacetyl-cholinového receptoru a/nebo serotonergické ligandy, způsob jejich přípravy a jejich použití
CZ291446B6 (cs) Derivát piperidinylmethyloxazolidinonu a farmaceutický prostředek, který ho obsahuje
SK2192002A3 (en) Piperidine alcohol derivative, process for the preparation and use thereof and pharmaceutical composition comprising same
EP0405905B1 (en) Use of Isoxazolin-3-one Derivatives as antidepressants
US4105795A (en) Antispasmodic substituted sulphoximides
MXPA01006230A (en) Sulphonyloxazolamines as therapeutic active ingredients
US20230406853A1 (en) Covalent cdk2-binding compounds for therapeutic purposes
GB2031427A (en) N-substituted cyclic amines their preparation and pharmaceutical compositions containing them
BG60318B2 (bg) Метод за получаване на триазолил тиоамидни производни
CZ9903260A3 (cs) Terapeutická činidla